Clomid (Clomiphene Citrate) for Secondary Hypogonadism: Evidence, Dosage, and Protocol

Understanding Secondary Hypogonadism

Hypogonadism, abnormally low testosterone, is classified by its origin in the HPG axis:

• Primary hypogonadism: Testicular failure. LH and FSH are high (pituitary is working hard), but testes don’t respond. Clomiphene is ineffective here, the problem is downstream.
• Secondary hypogonadism (central hypogonadism): The problem is in the hypothalamus or pituitary. LH and FSH are inappropriately low, and the testes are capable of producing testosterone if properly stimulated. Clomiphene is specifically effective for this type.

Secondary hypogonadism is the most common form in men under 50, often driven by obesity, metabolic syndrome, chronic illness, opioid use, or prior exogenous androgen exposure (anabolic steroids). Before starting clomiphene, confirming secondary status with bloodwork (low T + low/normal LH + low/normal FSH) is essential.

Clinical Evidence: Clomid for Secondary Hypogonadism

The clinical evidence base for clomiphene in male hypogonadism is robust and spans multiple decades.

The most comprehensive prospective study, Katz et al. (2012) , enrolled 86 hypogonadal men (total testosterone below 350 ng/dL) in an open-label trial with mean follow-up of 19 months. Clomiphene 25 to 50 mg every other day significantly increased mean testosterone from 237 to 610 ng/dL, a 157% increase, while LH increased from 4.5 to 9.0 IU/L and FSH from 6.4 to 10.5 IU/L. Crucially, testicular volume and semen parameters were maintained throughout treatment (Katz et al., 2012, doi:https://pubmed.ncbi.nlm.nih.gov/22044663/).

Taylor and Levine (2010) conducted a prospective trial in 36 hypogonadal men comparing clomiphene 25 mg/day, 50 mg every other day, and 25 mg every other day. All three dosing strategies significantly increased testosterone within 30 days. The 25 mg every-other-day protocol achieved mean testosterone of 503 ng/dL, within the normal range, with the fewest side effects.

Moskovic et al. (2012) retrospectively analyzed 69 hypogonadal men treated with clomiphene at a fertility clinic. Total testosterone normalized in 75% of men by the end of the first month. Importantly, 62% of men who were attempting to conceive achieved pregnancy during treatment, something testosterone replacement therapy would have precluded.

How Clomid Treats Secondary Hypogonadism

In secondary hypogonadism, the hypothalamus and/or pituitary are not producing adequate GnRH, LH, and FSH, typically due to hypersensitivity to estrogen’s inhibitory feedback signal. The testes are capable of making testosterone, but they’re not receiving the LH signal to do so.

Hypothalamic Estrogen Receptor Blockade

Clomiphene competitively binds to estrogen receptors in the hypothalamus and pituitary, preventing estradiol from exerting its normal inhibitory feedback. The hypothalamus, no longer perceiving adequate estrogen-mediated inhibition, increases GnRH pulsatility. This restores the signaling cascade: GnRH drives pituitary LH and FSH secretion, and LH drives testicular testosterone production.

Why Clomiphene Is Preferred Over TRT for Secondary Hypogonadism

Testosterone replacement therapy (TRT) corrects low testosterone but suppresses the HPG axis, reducing LH, FSH, testicular volume, and sperm production to near zero. For men with secondary hypogonadism who want to preserve or restore fertility, or who prefer to maintain intrinsic testicular function, clomiphene offers an alternative that:

• Raises endogenous testosterone to normal range
• Maintains or increases LH and FSH
• Preserves spermatogenesis and testicular volume
• Can be discontinued without prolonged axis suppression
• Is oral (no injections, patches, or gels)

Dosage Protocol for Secondary Hypogonadism

Clinical protocols for secondary hypogonadism use lower doses than PCT protocols:

• Starting dose: 25 mg every other day (12.5 mg/day average) , minimizes estrogenic effects while establishing response
• Standard therapeutic dose: 25 to 50 mg every other day, the most studied regimen in the Katz et al. cohort
• Daily dosing: 25 to 50 mg/day produces faster testosterone increases but higher rates of estrogen-related side effects; some clinicians prefer EOD for better tolerability
• Duration: Clomiphene can be used long-term (19+ months in Katz et al.) with no evidence of declining efficacy or adverse effects on testicular function

Monitoring protocol: Check total testosterone, LH, FSH, estradiol, and hematocrit at baseline and at 4 to 6 weeks. Adjust dose to target testosterone 500-700 ng/dL with LH in the 3-10 IU/L range. Elevated estradiol (above 40 pg/mL) with symptoms may warrant lower doses or addition of an aromatase inhibitor.

Comparison: Clomiphene vs Testosterone Replacement Therapy

Factor	Clomiphene (Clomid)	Testosterone Replacement
Route	Oral tablet	Injection, gel, patch
LH/FSH effect	Increases LH and FSH	Suppresses LH and FSH to zero
Testicular volume	Maintained or increased	Significantly reduced (atrophy)
Spermatogenesis	Maintained or improved	Severely suppressed
Fertility preservation	Yes	No (unless HCG is added)
Testosterone efficacy	Strong (157% increase)	Strong
Estradiol effect	May increase moderately	Increases (aromatization)
Cardiovascular risk	Not established / lower	Elevated hematocrit risk

Side Effects

At therapeutic doses for secondary hypogonadism, clomiphene is generally well-tolerated. The most commonly reported effects:

• Hot flashes: Mechanism-based (hypothalamic ER blockade) , occurs in ~10-20% of men
• Mood fluctuations: Less common at EOD dosing; related to partial estrogen agonism at peripheral tissues
• Elevated estradiol: Requires monitoring; treat with lower dose or adjunct AI if symptomatic
• Visual disturbances: Rare (<1%); discontinue immediately and seek ophthalmological evaluation if any visual changes occur

Frequently Asked Questions

Who is a good candidate for Clomid treatment of hypogonadism?

Men with confirmed secondary hypogonadism (low T + low or inappropriately normal LH/FSH + no structural pituitary pathology) who want to preserve fertility, prefer oral therapy, or wish to avoid the axis suppression and testicular atrophy of TRT. Men with primary hypogonadism (elevated LH/FSH with low T) are not candidates, the testes cannot respond to LH stimulation in that setting.

Can Clomid permanently restore testosterone levels?

In most cases, testosterone returns to pre-treatment levels after discontinuation, since clomiphene’s effect depends on continued receptor blockade. However, in some men, particularly those whose hypogonadism was driven by obesity or reversible metabolic factors, treating the underlying cause while on clomiphene can lead to sustained improvement after discontinuation. This is not predictable and should not be assumed.

What bloodwork do I need before starting Clomid for hypogonadism?

Minimum: Total testosterone (morning draw), LH, FSH, estradiol, prolactin, complete metabolic panel, CBC. Elevated prolactin indicates a need for pituitary MRI before starting clomiphene. The LH/FSH ratio and values help confirm secondary (central) rather than primary etiology.

How to Source Clomid in Canada

Elite Bio Supply carries pharmaceutical-grade Clomiphene Citrate with domestic shipping across Canada via Canada Post. All batches are third-party tested for purity and identity. View Clomid product page and order.

Related Guides

• Clomid Dosage Guide
• Clomid for Post-Cycle Therapy
• Buy Clomid in Canada
• Enclomiphene for Secondary Hypogonadism